World News: 13:30 GMT Wednesday 19th December 2018. [Melinta Therapeutics via Globe Newswire via SPi World News]
NEW HAVEN Conn Dec 19 2018 GLOBE NEWSWIRE -- Melinta Therapeutics Inc (NASDAQ: MLNT a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections today announced that it has received a commi...
Globe Newswire: 13:30 GMT Wednesday 19th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.